Cargando…
The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
BACKGROUND: The aim of this work is to evaluate the detection rate of magnetic resonance imaging/transrectal ultrasound (MRI/TRUS) fusion-guided biopsy for clinically significant prostate cancers (Cs PCas), with particular interest in biopsy-naive patients and patients in active surveillance. MRI-ta...
Autores principales: | Benelli, Andrea, Vaccaro, Chiara, Guzzo, Sonia, Nedbal, Carlotta, Varca, Virginia, Gregori, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238303/ https://www.ncbi.nlm.nih.gov/pubmed/32489424 http://dx.doi.org/10.1177/1756287220916613 |
Ejemplares similares
-
Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy
por: Zhang, Fan, et al.
Publicado: (2022) -
Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS
por: Birs, Antoinette, et al.
Publicado: (2016) -
The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
por: Zhang, Xin, et al.
Publicado: (2022) -
TRUS-MR Fusion Biopsy of the Prostate: Radiological and Histological Correlation
por: Lavaerts, Michel, et al.
Publicado: (2016) -
Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)